Cathodal tDCS showed significant decline in monthly seizures of MTLE-HS patients.
All patients tolerated tDCS well without safety problems.
Optimal stimulation parameters are not yet clarified for tDCS.
Cathodal tDCS may be used as an additional treatment option in MTLE-HS patients.